Investor
Biovance Capital
Lisbon · Portugal
Biovance Capital is a biotech venture capital firm investing in early-stage biopharma and transformative therapies across Europe.
Stage
Seed–Series A
Sectors
Not confirmed
Cheque
Up to €4m
Invests in
3 countries
Invests in
About
Biovance Capital focuses on early-stage biopharma companies across Europe. The firm targets seed and Series A rounds, particularly within Southern European countries. They support biotech companies developing therapeutics across any modality and therapeutic area. The team requires robust preclinical models and patentable assets before committing capital. They work closely with entrepreneurs to build companies providing transformative treatments for patients.
How to approach
Submit investment opportunities through the contact form only if they align with the criteria on the about page.
Portfolio · 3 · tap a company to read about it